Free Trial
NASDAQ:RVPH

Reviva Pharmaceuticals (RVPH) Stock Price, News & Analysis

Reviva Pharmaceuticals logo
$0.41 -0.02 (-5.04%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$0.41 +0.00 (+0.22%)
As of 08/8/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Reviva Pharmaceuticals Stock (NASDAQ:RVPH)

Key Stats

Today's Range
$0.40
$0.44
50-Day Range
$0.34
$0.88
52-Week Range
$0.30
$4.28
Volume
1.94 million shs
Average Volume
2.52 million shs
Market Capitalization
$19.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00
Consensus Rating
Buy

Company Overview

Reviva Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

RVPH MarketRank™: 

Reviva Pharmaceuticals scored higher than 52% of companies evaluated by MarketBeat, and ranked 491st out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Reviva Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.29, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Reviva Pharmaceuticals has only been the subject of 1 research reports in the past 90 days.

  • Read more about Reviva Pharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for Reviva Pharmaceuticals are expected to grow in the coming year, from ($0.97) to ($0.79) per share.

  • Price to Book Value per Share Ratio

    Reviva Pharmaceuticals has a P/B Ratio of 20.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Reviva Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    12.60% of the outstanding shares of Reviva Pharmaceuticals have been sold short.
  • Short Interest Ratio / Days to Cover

    Reviva Pharmaceuticals has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Reviva Pharmaceuticals has recently increased by 68.99%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Reviva Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Reviva Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.60% of the outstanding shares of Reviva Pharmaceuticals have been sold short.
  • Short Interest Ratio / Days to Cover

    Reviva Pharmaceuticals has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Reviva Pharmaceuticals has recently increased by 68.99%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    29 people have searched for RVPH on MarketBeat in the last 30 days. This is an increase of 71% compared to the previous 30 days.
  • MarketBeat Follows

    11 people have added Reviva Pharmaceuticals to their MarketBeat watchlist in the last 30 days. This is an increase of 57% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Reviva Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    27.18% of the stock of Reviva Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    63.18% of the stock of Reviva Pharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Reviva Pharmaceuticals' insider trading history.
Receive RVPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RVPH Stock News Headlines

#1 Pre-IPO Opportunity For 2025 [Take Action Now!]
James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opportunity is taking shape—one tied to what could be the largest IPO in history: Elon Musk’s Starlink. With the IPO rumored to launch as soon as this year, James has uncovered a backdoor method to potentially profit before it goes public—starting with as little as $50.
Reviva Dives on Stock Offering
See More Headlines

RVPH Stock Analysis - Frequently Asked Questions

Reviva Pharmaceuticals' stock was trading at $1.81 on January 1st, 2025. Since then, RVPH shares have decreased by 77.5% and is now trading at $0.4071.

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) posted its earnings results on Thursday, May, 15th. The company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.21) by $0.08.

Top institutional shareholders of Reviva Pharmaceuticals include Geode Capital Management LLC (0.93%), Simplex Trading LLC and Quaker Wealth Management LLC. Insiders that own company stock include Prabhu Narayan and Purav Patel.
View institutional ownership trends
.

Shares of RVPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Reviva Pharmaceuticals investors own include Sangamo Therapeutics (SGMO), Salesforce (CRM), Adobe (ADBE), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Airbnb (ABNB) and Marvell Technology (MRVL).

Company Calendar

Last Earnings
5/15/2025
Today
8/10/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RVPH
CIK
1742927
Fax
N/A
Employees
5
Year Founded
N/A

Price Target and Rating

High Price Target
$17.00
Low Price Target
$3.00
Potential Upside/Downside
+2,110.8%
Consensus Rating
Buy
Rating Score (0-4)
3.29
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.79)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$29.92 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-302.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.54
Quick Ratio
0.54

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.02 per share
Price / Book
20.36

Miscellaneous

Outstanding Shares
48,000,000
Free Float
34,957,000
Market Cap
$19.54 million
Optionable
Optionable
Beta
-0.05

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:RVPH) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners